Patients received 20,000 IU of epoetin alfa subcutaneously every 2 wk for up to 27 wk, with dosage adjustments permitted after 4 wk of treatment.

 
  • 病人每?jì)芍芙邮?次重組人紅細胞生成素皮下注射,直到第27周,在用藥第4周后允許對用藥量進(jìn)行調整。
今日熱詞
目錄 附錄 查詞歷史
国内精品美女A∨在线播放xuan